MS
Insider
Michael P Stansky
DirectorMichael P Stansky (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in TriSalus Life Sciences, Inc. (TLSI). Across 2 priced purchase filings, the average 21-session return was +20.5% from execution and +13.7% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of TLSI (610,000 sh across 2 lots, as filed), executed May 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.5%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+13.7%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.0M
shares × price, as filed
Last traded
May 15
Filed May 18
Volume by month
Buys $3.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
TLSIRecent filings
TLSIPURCHASE
TriSalus Life Sciences, Inc.
View filing →
$1.5M610,000 sh across 2 lots
Exec May 15
Filed May 18 · 4:42 PM ET TLSIPURCHASE TriSalus Life Sciences, Inc. View filing → $1.5M
361,098 sh across 2 lots
Exec Feb 23
Filed Feb 23 · 4:08 PM ET